drugset / Trial / NCT01109173
Confirmatory Study Nepafenac 0.3%
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study was to assess the safety and efficacy of an investigational eye drop intended for the prevention and treatment of inflammation (swelling and redness) and pain in the eye after cataract extraction.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nepafenac | Other / unclassified | 0.1 % | Other |
| Subject | Nepafenac | Other / unclassified | 0.3 % | Other |